Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
Pre-Tax Income
Cyclopharm Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Cyclopharm Ltd
ASX:CYC
|
Pre-Tax Income
-AU$4.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
Neurotech International Ltd
ASX:NTI
|
Pre-Tax Income
-AU$5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Pre-Tax Income
-AU$19.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-11%
|
|
Cochlear Ltd
ASX:COH
|
Pre-Tax Income
AU$468.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
18%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Pre-Tax Income
-AU$5.4m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-11%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Pre-Tax Income
-AU$3.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Pre-Tax Income?
Pre-Tax Income
-4.2m
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Pre-Tax Income amounts to -4.2m AUD.
What is Cyclopharm Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
9%
Over the last year, the Pre-Tax Income growth was 31%. The average annual Pre-Tax Income growth rates for Cyclopharm Ltd have been 11% over the past three years , and 9% over the past ten years .